Biotechnology Regulations

24
Biotechnology Regulations Chapter 12

description

Biotechnology Regulations. Chapter 12. The Regulatory Framework. U.S. Department of Agriculture Safe to Grow Environmental Protection Agency Safe for the Environment Food and Drug Administration Safe to Consume All 3 agencies work together!. U.S. Department of Agriculture. - PowerPoint PPT Presentation

Transcript of Biotechnology Regulations

Page 1: Biotechnology Regulations

Biotechnology Regulations

Chapter 12

Page 2: Biotechnology Regulations

The Regulatory FrameworkU.S. Department of Agriculture• Safe to Grow

Environmental Protection Agency• Safe for the Environment

Food and Drug Administration• Safe to Consume

All 3 agencies work together!

Page 3: Biotechnology Regulations

U.S. Department of AgricultureCreated in 1862Regulation of plant pests, plants and

veterinary biologics (defined as any medical preparation made from living organisms or products (e.g. insulin and vaccines)

Animal and Plant Health Inspection Service (APHIS) - Responsible for protecting U.S. agriculture from pests and diseases

Page 4: Biotechnology Regulations

U.S. Department of AgriculturePermitting Process

• Several years of field trials• Petition for deregulation (plant pest

consequences, risk to other organisms, weed consequences)

• Notification Process or “fast track”

Page 5: Biotechnology Regulations

The Environmental Protection Agency

Established in 1970Experimental Use Permit (plants themselves

must meet the same standards as chemical pesticides used in the fields)

First one issued was to Advanced Genetic Sciences Inc. in 1985

Next phase, deregulation and commercialization (considers the gene, its regulation, and the protein; then health effects; environmental fate, effect on non-targeted species)

Page 6: Biotechnology Regulations

Food and Drug AdministrationConsults with companies to produce safe

productsIf a food or additive poses no foreseeable

threat, it is granted generally-recognized-as-safe (GRAS) status (e.g. genetically engineered chymosin and BST)

Page 7: Biotechnology Regulations

Food and Drug Administration The Drug Approval Process

• GLPs –regulations governing animal studies• GCPs –regulations governing human studies• After animal trials- apply for Investigational New Drug

status (IND)• Phase I(safety)-20 to 80 healthy people; determine ADME• Phase II(efficacy)-100 to 300 patients • Phase III- 1,000 to 3,000 patients in double blinded tests• Only 20% make it to NDA• EXCEPTION- fast track status to drugs that counter

biological, chemical and nuclear terrorism and orphan drugs

Page 8: Biotechnology Regulations

Legislation and RegulationPhilosophical values vs scientific

evidence • Stem Cell Research• Labeling Biotech products

Page 9: Biotechnology Regulations

Introduction to PatentsUS Patent and Trademark Office (USPTO)

issued the first patent on a bacterium in 1980

Simple guidelines to protect a product:• Keep good records• Do your homework

Page 10: Biotechnology Regulations

Introduction to PatentsNovelNon-obviousSome UtilityPatenting DNA Sequences

• Specific utility (what the sequence does)• Substantial utility (“real world” use)• Credible utility (sound science)

Page 11: Biotechnology Regulations

Biotechnology Products in the Global Marketplace

The world community is still involved in preliminary negotiations• UN –voluntary code and a set of technical

guidelines concerning the release of GMOs• FAO focusing its attention on biotech in

developing nations• EU through the EMEA is the counterpart of the

FDA (except it doesn’t get involved in product development)

Page 12: Biotechnology Regulations

Ethics and Biotechnology

Chapter 13

Page 13: Biotechnology Regulations

What is Ethics?It considers social and moral aspects and

potential outcomes of the use of biological and medical techniques

Ask yourself, “Should this be done?” and then “How can it be done in the right way?”

Page 14: Biotechnology Regulations

What is Ethics?Approaches To Ethical Decision Making• The FIRST: Hippocratic Oath-”do not kill” or “to

help or at least do not harm”

• Two approaches:• Utilitarian or consequences-the ends justify the

means• Deontological or objectivism-there are at least some

absolutes (definitive rules that cannot be broken)

Page 15: Biotechnology Regulations

What is Ethics?Ethical Exercise Warm-Up• Should you push that guys in front of the car

containing 3 children or not?

Page 16: Biotechnology Regulations

Biotechnology and NatureAsilomar Conference- called for a

moratorium on DNA recombinant research until guidelines could be established

Page 17: Biotechnology Regulations

Biotechnology and NatureCells and Products• What are some of the ethical considerations

associated with animal trials for human drugs?• Safety• Efficacy• Humane treatment of animals in studies

• How many animals and which animal model? (e.g. thalidomide was originally tested in rodents and found safe however, after birth defects occurred, it was then tested in marmosets and birth defects occurred in the baby monkeys)

Page 18: Biotechnology Regulations

Biotechnology and Nature GM Crops: Are You What You Eat?

• Areas of concern:• Do the alterations in the plant benefit it or at

least do not produce a less vigorous plant?• Is the integrity of the species maintained?• Is the biodiversity of the species altered or the

biodiversity of any insects dependent on this plant?

• What is the statistical probability of a bad event happening (e.g. transfer of the gene to another plant)?

• How safe is the new product? (e.g can humans become allergic to Bt?)

• What are the social and economic ramifications of introducing this plant? (e.g. farmers who recycle Roundup-Ready soybeans and therefore are stealing from Monsanto)

Page 19: Biotechnology Regulations

Biotechnology and Nature Animal Husbandry or Animal Tinkering

• Raises some of the some questions as in plant tinkering• What are some of the early modifications? (antibiotics and

hormone treatments)• There is little concern about the effect of genetically

modified ag animals on the environment, but is this appropriate? The effect on biodiversity?

• What about species integrity? Consider whether there is a point at which the animal might acquire enough human genes to be considered human? (what defines being a human?)

Page 20: Biotechnology Regulations

Biotechnology and NatureThe Human Question• Controversial issues surround the testing of

drugs on humans, why?• Who should get the drug (the sickest?)• Why is informed consent so important-do you

think parents should be allowed to decide for a child?

• The placebo problem in the double-blind test (someone is going to get a “sugar” pill)

Page 21: Biotechnology Regulations

Biotechnology and Nature What Does It Mean to Be Human?

• Current ethical debates revolve around the moral status of the human embryo—is it a human being?

• Does it qualify for personhood (defines an entity that qualifies for protection based not on an intrinsic value but rather on certain attributes such as self-awareness)

• AND what about the idea of creating embryos for an ES cell source vs spare or disregarded embryos?

• AND does creating embryos lead to human commercialization-making human life a commodity to be bought and sold?

Page 22: Biotechnology Regulations

Biotechnology and NatureRegulations in Flux• Federal ban on federal funding of stem cell

research has been reversed.

Page 23: Biotechnology Regulations

Biotechnology and NatureMore or Less Human?• What are the implications of germline genetic

engineering? (Who decides what makes a better human being? What changes are allowed?)

Page 24: Biotechnology Regulations

Economics, The Role of Science, and Communication

Grant funding is based on peer review